Hana F Zickgraf1,2, Helen B Murray3, Hilary E Kratz4, Martin E Franklin2. 1. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois. 2. Child and Adolescent OCD, Tic, Trich, and Anxiety Group (COTTAGe), Perelman School of Medicine, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Psychology, Drexel University, Philadelphia, Pennsylvania. 4. Department of Psychology, La Salle University, Philadelphia, Pennsylvania.
Abstract
OBJECTIVE: Although Avoidant/Restrictive Food Intake Disorder (ARFID) has existed since the publication of DSM-5 in 2013, research on the descriptive psychopathology of treatment-seeking patients with formal ARFID diagnoses is sparse, and limited to tertiary eating disorder-focused treatment settings where most patients present with weight loss/malnutrition. In these settings, the selective/neophobic symptom presentation is rare compared to other primary eating restrictions. We aimed provide initial descriptive psychopathology of ARFID primary selective/neophobic symptom presentation in an outpatient setting, and to explore the prevalence of the core ARFID symptoms and clinical differences among patients meeting criteria based on weight/nutritional symptoms versus psychosocial impairment only. METHOD: We reviewed the charts of 22 consecutive outpatients diagnosed with ARFID caused by selective/neophobic eating, and describe symptoms, impairment, illness trajectory, and demographic features. Patients who met ARFID criteria because of weight loss/nutritional problems were compared to those who met for psychosocial impairment only on demographic and clinical characteristics. RESULTS: Patients were predominantly male (81.8%) and school-aged (4-11 years). 81.8% had no weight/nutritional symptoms documented by a medical provider. All met criteria for significant psychosocial impairment. There were few differences between patients who did versus did not meet weight loss/nutritional criteria for ARFID; they differed only in age and in the presence of appetite disturbances consistent with another proposed presentation of ARFID. DISCUSSION: These results provide novel data on the clinical characteristics of individuals who present with a primary presentation of selective/neophobic ARFID, including support for psychosocial impairment as sufficient for fulfilling ARFID criterion A.
OBJECTIVE: Although Avoidant/Restrictive Food Intake Disorder (ARFID) has existed since the publication of DSM-5 in 2013, research on the descriptive psychopathology of treatment-seeking patients with formal ARFID diagnoses is sparse, and limited to tertiary eating disorder-focused treatment settings where most patients present with weight loss/malnutrition. In these settings, the selective/neophobic symptom presentation is rare compared to other primary eating restrictions. We aimed provide initial descriptive psychopathology of ARFID primary selective/neophobic symptom presentation in an outpatient setting, and to explore the prevalence of the core ARFID symptoms and clinical differences among patients meeting criteria based on weight/nutritional symptoms versus psychosocial impairment only. METHOD: We reviewed the charts of 22 consecutive outpatients diagnosed with ARFID caused by selective/neophobic eating, and describe symptoms, impairment, illness trajectory, and demographic features. Patients who met ARFID criteria because of weight loss/nutritional problems were compared to those who met for psychosocial impairment only on demographic and clinical characteristics. RESULTS:Patients were predominantly male (81.8%) and school-aged (4-11 years). 81.8% had no weight/nutritional symptoms documented by a medical provider. All met criteria for significant psychosocial impairment. There were few differences between patients who did versus did not meet weight loss/nutritional criteria for ARFID; they differed only in age and in the presence of appetite disturbances consistent with another proposed presentation of ARFID. DISCUSSION: These results provide novel data on the clinical characteristics of individuals who present with a primary presentation of selective/neophobic ARFID, including support for psychosocial impairment as sufficient for fulfilling ARFID criterion A.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Sara F Forman; Nicole McKenzie; Rebecca Hehn; Maria C Monge; Cynthia J Kapphahn; Kathleen A Mammel; S Todd Callahan; Eric J Sigel; Terrill Bravender; Mary Romano; Ellen S Rome; Kelly A Robinson; Martin Fisher; Joan B Malizio; David S Rosen; Albert C Hergenroeder; Sara M Buckelew; M Susan Jay; Jeffrey Lindenbaum; Vaughn I Rickert; Andrea Garber; Neville H Golden; Elizabeth R Woods Journal: J Adolesc Health Date: 2014-09-04 Impact factor: 5.012
Authors: P Evelyna Kambanis; Megan C Kuhnle; Olivia B Wons; Jenny H Jo; Ani C Keshishian; Kristine Hauser; Kendra R Becker; Debra L Franko; Madhusmita Misra; Nadia Micali; Elizabeth A Lawson; Kamryn T Eddy; Jennifer J Thomas Journal: Int J Eat Disord Date: 2019-11-08 Impact factor: 4.861
Authors: Stephanie G Harshman; Jenny Jo; Megan Kuhnle; Kristine Hauser; Helen Burton Murray; Kendra R Becker; Madhusmita Misra; Kamryn T Eddy; Nadia Micali; Elizabeth A Lawson; Jennifer J Thomas Journal: J Clin Psychiatry Date: 2021-09-07 Impact factor: 4.384
Authors: Helen Burton Murray; Melissa J Dreier; Hana F Zickgraf; Kendra R Becker; Lauren Breithaupt; Kamryn T Eddy; Jennifer J Thomas Journal: Int J Eat Disord Date: 2021-04-22 Impact factor: 4.861
Authors: Annieke Venema; Fabian Peeks; Marlies de Bruijn-van der Veen; Foekje de Boer; Marieke J Fokkert-Wilts; Charlotte M A Lubout; Bibi Huskens; Eric Dumont; Sandra Mulkens; Terry G J Derks Journal: JIMD Rep Date: 2021-10-10
Authors: Mark L Norris; Nicole Obeid; Alexandre Santos; Darcie D Valois; Leanna Isserlin; Stephen Feder; Wendy Spettigue Journal: Front Psychiatry Date: 2021-07-16 Impact factor: 4.157